First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral load. - Wikidata - wikimedia - TriplyDB

First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.

First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.

http://www.wikidata.org/entity/Q37354804

about

First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.

http://www.wikidata.org/entity/Q37354804

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

First-line cART regimen impact ...... ained undetectable viral load.

@en

First-line cART regimen impact ...... ained undetectable viral load.

@nl

type

label

First-line cART regimen impact ...... ained undetectable viral load.

@en

First-line cART regimen impact ...... ained undetectable viral load.

@nl

prefLabel

First-line cART regimen impact ...... ained undetectable viral load.

@en

First-line cART regimen impact ...... ained undetectable viral load.

@nl

P1433

Q37354804-3DECC454-489C-4034-AC08-590DC40B6FCA

P1476

Q37354804-B1216186-62EC-4332-8467-7F6735153125

P2093

Q37354804-081C2A00-81E8-40F2-9315-34334915B4FB

Q37354804-1012E9AD-7C4C-4E64-8F92-431103F37A9D

Q37354804-1F375F36-2210-4B08-BA4B-DE9C4F53605C

Q37354804-22A0A94D-5E18-4447-AE72-559A5D44DBDD

Q37354804-49FCCE1F-CE39-4E4C-B1C5-2DA4F29BF075

Q37354804-4B4E49D5-C61E-42C1-95B7-2C1748AE70C2

Q37354804-57E69A09-F930-47FA-8B1F-CF58AF8734C0

Q37354804-6ECA0EE6-C817-4946-A5C4-DD1E2CCA98F6

Q37354804-85642C00-01B1-4700-A67D-BD91A663BFC3

Q37354804-86F5440C-E886-44C2-A3CA-1B9EF8662C1D

P2860

Q37354804-17414F63-1E9F-455A-8B78-6EF246E3BB52

Q37354804-1A549CB2-CA99-4E0B-9750-E58BADC5DBFE

Q37354804-20BD9C03-4854-4E63-9AF9-B3C9C83F1A2A

Q37354804-2115E40E-1776-48D4-8E46-22C69BFEFA03

Q37354804-23A7780F-BA57-493D-AAC4-362EB0233A41

Q37354804-265D2C0A-6F5B-4A54-807B-64B8DBF5588C

Q37354804-2C692B77-5BF5-4F27-BA79-D272481F182F

Q37354804-4486B2B5-5148-40AD-8E00-D6A4CCBDF805

Q37354804-505BA0E5-C4D6-4295-8AF2-165F6AAEECE1

Q37354804-519AE0A7-1829-4331-8993-04B10E53EBB4

P304

Q37354804-2818D0CC-3FF4-4BF6-95A0-E9712F0C2CAC

P31

Q37354804-3632441C-D888-4779-B859-D4D09E8F8A96

P356

Q37354804-8C8E55FA-6AC9-43D0-96E5-A442E8585FF9

P407

Q37354804-14291B38-ED3B-4296-9EEB-95A47931AEC4

P433

Q37354804-13D679AB-DBB2-4517-B888-25D06E43352C

P478

Q37354804-4162783F-21D6-4CEA-922D-19427F20B54E

P50

Q37354804-4169DE4F-F36A-4160-A38B-8D0C3E3B90FD

Q37354804-612777EE-4905-459E-B5FD-F3892B58330A

Q37354804-69B9DFD7-EA8F-4424-A520-8CA41410BE38

Q37354804-FCCC1ED6-EE8B-40DF-B789-27066C028A9E

P577

Q37354804-1CAC6D0E-6D31-4FEA-A102-BB86872774E7

P698

Q37354804-6C1E2522-B088-430E-B438-7E221F941E56

P921

Q37354804-5D36834F-0D02-4307-A879-90BA44A820BE

P932

Q37354804-6F5703B6-6024-4D8E-A6D1-7EF12783994F

P356

MD.0000000000005087

P1433

P1476

First-line cART regimen impact ...... ained undetectable viral load.

@en

P2093

André Cabié

http://www.w3.org/2001/XMLSchema#string

Antoine Cheret

http://www.w3.org/2001/XMLSchema#string

Bruno Hoen

http://www.w3.org/2001/XMLSchema#string

Carla E Cano

http://www.w3.org/2001/XMLSchema#string

Claudine Duvivier

http://www.w3.org/2001/XMLSchema#string

Clotilde Allavena

http://www.w3.org/2001/XMLSchema#string

Cyrille Delpierre

http://www.w3.org/2001/XMLSchema#string

Dat’AIDS Study Group

http://www.w3.org/2001/XMLSchema#string

David Rey

http://www.w3.org/2001/XMLSchema#string

Francine Guillouet de Salvador

http://www.w3.org/2001/XMLSchema#string

P2860

Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine

Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection.

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.

The role of CD8+ T-cell replicative senescence in human aging.

CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies.

Immunological recovery and antiretroviral therapy in HIV-1 infection.

Multiparametric bioinformatics distinguish the CD4/CD8 ratio as a suitable laboratory predictor of combined T cell pathogenesis in HIV infection.

Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.

Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.

P304

e5087

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000005087

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Clotilde Allavena

Isabelle Poizot-Martin

Christine Katlama

Francine Guillouet de Salvador

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27741125

http://www.w3.org/2001/XMLSchema#string

P921

P932

5072952

http://www.w3.org/2001/XMLSchema#string